Company Description
GLS (NYSE: GLS) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.
GLS stock has declined 96.9% over the past year.
This page provides a comprehensive overview of GLS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
GLS (GLS) stock. Over the past 12 months, the stock has lost 96.9%.
Latest News
GLS has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, clinical trial. View all GLS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GLS Company Profile & Sector Positioning
GLS (GLS) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NYSE.